Baker Bros Advisors LP Has Decreased Its Position in Achaogen INC (AKAO) as Stock Rose

March 14, 2018 - By Dolores Ford

Investors sentiment decreased to 1.16 in Q3 2017. Its down 1.22, from 2.38 in 2017Q2. It fall, as 23 investors sold AKAO shares while 20 reduced holdings. 14 funds opened positions while 36 raised stakes. 31.77 million shares or 0.83% less from 32.03 million shares in 2017Q2 were reported. Ameritas Investment Prtn holds 0% or 2,546 shares. Weiss Multi, a Alabama-based fund reported 35,500 shares. 5.06M are held by Fmr Llc. State Street, Massachusetts-based fund reported 1.96 million shares. Vanguard Gru invested in 0% or 1.53M shares. Us Bank & Trust De has 0% invested in Achaogen, Inc. (NASDAQ:AKAO). 27,551 were accumulated by Perceptive Lc. State Board Of Administration Of Florida Retirement Sys owns 16,486 shares. Blair William Il has invested 0% in Achaogen, Inc. (NASDAQ:AKAO). 293,612 were accumulated by Geode Mngmt Ltd Liability Company. Lord Abbett And Com Ltd Liability Com invested 0.02% of its portfolio in Achaogen, Inc. (NASDAQ:AKAO). Alliancebernstein Limited Partnership stated it has 107,400 shares. Artal Grp Incorporated holds 0.07% or 250,000 shares in its portfolio. Polar Limited Liability Partnership holds 1.90 million shares or 0.34% of its portfolio. National Bank & Trust Of New York Mellon has invested 0% in Achaogen, Inc. (NASDAQ:AKAO).

Since September 26, 2017, it had 4 buys, and 6 insider sales for $7.18 million activity. 3,576 shares were sold by Wise Blake, worth $57,180. Swem Lee also sold $13,679 worth of Achaogen, Inc. (NASDAQ:AKAO) shares. Another trade for 4,606 shares valued at $49,146 was made by Hillan Kenneth J. on Wednesday, February 21. $11,822 worth of Achaogen, Inc. (NASDAQ:AKAO) shares were sold by Schilke Tobin. LOEB GARY sold $18,325 worth of stock or 1,146 shares.

Julian Baker decreased its stake in Achaogen Inc. (AKAO) by 19.1% based on its latest 2017Q3 regulatory filing with the SEC. Baker Bros Advisors Lp sold 917,726 shares as the company’s stock rose 8.95% with the market. The hedge fund run by Julian Baker held 3.89M shares of the health care company at the end of 2017Q3, valued at $62.00 million, down from 4.80 million at the end of the previous reported quarter. Baker Bros Advisors Lp who had been investing in Achaogen Inc. for a number of months, seems to be less bullish one the $518.82M market cap company. The stock increased 0.87% or $0.1 during the last trading session, reaching $11.6. About 506,314 shares traded. Achaogen, Inc. (NASDAQ:AKAO) has risen 757.99% since March 14, 2017 and is uptrending. It has outperformed by 741.29% the S&P500.

Baker Bros Advisors Lp, which manages about $8.20 billion and $12.33 billion US Long portfolio, upped its stake in Sage Therapeutics Inc. (NASDAQ:SAGE) by 197,157 shares to 405,485 shares, valued at $25.26 million in 2017Q3, according to the filing. It also increased its holding in Beigene Ltd. by 225,256 shares in the quarter, for a total of 3.90M shares, and has risen its stake in Avexis Inc..

Analysts await Achaogen, Inc. (NASDAQ:AKAO) to report earnings on May, 14. They expect $-0.92 EPS, down 80.39 % or $0.41 from last year’s $-0.51 per share. After $-0.98 actual EPS reported by Achaogen, Inc. for the previous quarter, Wall Street now forecasts -6.12 % EPS growth.

More news for Achaogen, Inc. (NASDAQ:AKAO) were recently published by:, which released: “Achaogen to Present at the Cowen and Company 38th Annual Health Care Conference” on March 06, 2018.‘s article titled: “Achaogen to Present at Needham & Company’s 17th Annual Healthcare Conference” and published on March 14, 2018 is yet another important article.

Achaogen, Inc. (NASDAQ:AKAO) Ratings Coverage

Among 10 analysts covering Achaogen (NASDAQ:AKAO), 9 have Buy rating, 1 Sell and 0 Hold. Therefore 90% are positive. Achaogen had 25 analyst reports since March 16, 2016 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, November 9. The rating was downgraded by Cowen & Co on Thursday, March 31 to “Market Perform”. Mizuho maintained the stock with “Buy” rating in Wednesday, February 28 report. The firm has “Hold” rating by Needham given on Wednesday, March 16. Aegis Capital initiated the shares of AKAO in report on Wednesday, November 2 with “Buy” rating. The firm has “Outperform” rating given on Wednesday, January 4 by Leerink Swann. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, February 7. The stock has “Buy” rating by Cowen & Co on Thursday, June 1. On Tuesday, January 2 the stock rating was maintained by Cowen & Co with “Buy”. The firm has “Buy” rating by Wedbush given on Wednesday, February 14.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: